Canlyniadau chwilio am the

Case study: A biomedical scientist’s employer raised concerns following an incident where the registrant failed to follow procedure. When processing samples, the registrant failed to prevent contamination, which led to inaccurate results.

As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.

Find individual position statements from the HCPC

Insights into the 2020-21 education dataset.

For applicants who trained outside the United Kingdom

The first page you’ll see is the ‘Before we begin’ page

Karen Philpotts, Head of Clinical Standards (MSH and MH) at Optima Health, shares a case study on the impact of well-supported CPD on one practitioner and their team.

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

In this webinar we will explore the requirement to the requirement to look after your own health and wellbeing, ensuring you are fit to practise.

Annual reports on the gender and ethnicity pay gaps, with this year marking the first publication of the disability pay gap.

Snapshot of outcomes related to the HCPC’s education function for the 2018-19 academic year

For those who practised as part of the COVID-19 recovery, our returning to practice processes will take into account any impact this may have had on the wider healthcare workforce.

The first page you’ll see is the ‘Before we begin’ page

Read about the equality, diversity and inclusion activities we undertake